Editorial & Opinion
Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy.
| العنوان: | Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy. |
|---|---|
| المؤلفون: | Danesh MJ; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. mdanesh@mgh.harvard.edu., Mulvaney PM; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Murakami N; Division of Nephrology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Riella LV; Division of Nephrology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schmults CD; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. |
| المصدر: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Sep; Vol. 69 (9), pp. 1937-1941. Date of Electronic Publication: 2020 Jun 25. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Berlin : Springer Verlag Original Publication: Berlin ; New York, NY : Springer International, c1982- |
| مواضيع طبية MeSH: | Adrenal Cortex Hormones/*therapeutic use , Antibodies, Monoclonal, Humanized/*therapeutic use , Graft Rejection/*prevention & control , Kidney Transplantation/*adverse effects , Programmed Cell Death 1 Receptor/*antagonists & inhibitors, Aged ; Allografts ; Female ; Graft Rejection/drug therapy ; Graft Rejection/immunology ; Humans ; Immunotherapy/methods ; Male ; Methylprednisolone/therapeutic use ; Middle Aged ; Prednisone/therapeutic use ; Programmed Cell Death 1 Receptor/immunology |
| References: | N Engl J Med. 2017 Jan 12;376(2):191-192. (PMID: 28076715) Kidney360. 2020 Jan 14;1(2):130-140. (PMID: 35372904) J Immunother Cancer. 2019 Apr 16;7(1):106. (PMID: 30992053) Oncologist. 2020 Jun;25(6):505-514. (PMID: 32043699) Int J Mol Sci. 2019 Feb 11;20(3):. (PMID: 30754640) |
| معلومات مُعتمدة: | K08 DK120868 United States DK NIDDK NIH HHS |
| المشرفين على المادة: | 0 (Adrenal Cortex Hormones) 0 (Antibodies, Monoclonal, Humanized) 0 (PDCD1 protein, human) 0 (Programmed Cell Death 1 Receptor) 6QVL057INT (cemiplimab) DPT0O3T46P (pembrolizumab) VB0R961HZT (Prednisone) X4W7ZR7023 (Methylprednisolone) |
| تواريخ الأحداث: | Date Created: 20200627 Date Completed: 20200831 Latest Revision: 20240329 |
| رمز التحديث: | 20240329 |
| مُعرف محوري في PubMed: | PMC7479641 |
| DOI: | 10.1007/s00262-020-02644-2 |
| PMID: | 32588077 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-020-02644-2 |